Article · 29 Aug 2026
Conference abstract
Particulate systems-mediated DNA vaccines
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vaccines are expected to give lifetime protection from infectious diseases, ideally with a single immunization. An ideal vaccine should have the characteristics such as long-term immunity and efficacy with single dose and easy administration, simple manufacturing properties, resistance to temperature changes and multivalency. DNA based vaccines are among the latest developments in vaccine technology and consist of DNA plasmids containing the genetic sequence encoding desired antigens with the supporting transcriptional elements that ultimately allow efficient protein production. The advantages of DNA vaccines over conventional vaccines are the higher stability of pDNA, lower costs, decreasing the risks of infections due to weakened viral vaccines, ability to increase the multi-target antigen capacity on the plasmid and to generate humoral and cellular immune response. It has been observed in the study carried out that therapeutic immune responses are generated in many animal models as a result of the injection of the antigen coding DNA to the interior of the muscle. However, pDNA has low effectiveness due to the breakdown via enzymes after being administered to the muscle. That is why systems are needed that can protect the DNA from the effects of enzymes. In general, cationic and especially polymeric and lipidic transport systems have been used as DNA carrying systems for different administration routes such as oral, intramuscular, subcutaneous, vaginal and nasal. When compared with the breakdown of DNA as a result of the enzymes in the bodily fluids, it has been observed that the DNA encapsulated in particulate systems are better preserved than adsorbed naked DNA.
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Gulay Buyukkoroglu”
